The world's first BCMA CAR-T therapy! Two-year data on Bristol-Myers Abecma's treatment of multiple myeloma: deep and lasting relief, predictable...
Drugs
2021 GINA guide: Can Azithromycin Cure Asthma? 2021 GINA guide: Can Azithromycin Cure Asthma? Can Azithromycin Cure Asthma? Check...
Amoxicillin is a panacea? Be vigilant, taking indiscriminately can cause death! Amoxicillin: Taking it indiscriminately may cause death! As long...
The magical effect of Netformin! It can promote the release of extracellular vesicles of mesenchymal stem cells and optimize the...
U.S. high-priced drug channel reform: Breaking the PBM monopoly U.S. high-priced drug channel reform: Breaking the PBM monopoly. In United...
The 5-year survival rate for advanced lung cancer doubles! Keytruda single-agent first-line treatment long-term data Keytruda: The 5-year...
New psychiatric drug: BXCL501 is under review in United States! New psychiatric drug: BXCL501 is under review in United...
CAR-T cells targeting B7-H3 solid tumors CAR-T cells targeting B7-H3 solid tumors. The high expression of B7-H3 in a variety...
AstraZeneca New drug: Fasenra for severe eosinophilic asthma AstraZeneca New drug: Fasenra for severe eosinophilic asthma. AstraZeneca Fasenra in...
TIGIT: What is the prospect of clinical application in the future? TIGIT: What is the prospect of clinical application...
New drug for metastatic breast cancer (mBC): Halaven (Eribulin) New drug for metastatic breast cancer (mBC): Halaven (Eribulin). Eisai...
Antigen recognition combination to overcome specificity, heterogeneity and durability challenges in Glioblastoma T cell therapy Challenges: Antigen recognition combination...
Many drugs that are not originally related to immunity are often found to participate in immune regulation Many drugs...
Roche/Regeneron antibody REGEN-COV reduced 70% COVID-19 death risks! Roche/Regeneron antibody REGEN-COV reduced 70% COVID-19 death risks! Roche/Regeneron antibody cocktail...
Bayer New drug Finerenone for diabetic nephropathy! Bayer New drug Finerenone for diabetic nephropathy! New medicine for diabetic nephropathy!...
JAK inhibitor Ruxolitinib: The first drug therapy for vitiligo! JAK inhibitor Ruxolitinib: The first drug therapy for vitiligo! The first...
How to use antibiotics for urinary tract infections? How to use antibiotics for urinary tract infections? These tips may...
The history and current status of KRAS target The history and current status of KRAS target. The full name...
Can HER3 become a medicine even it is quite different from HER2? Can HER3 become a medicine even it...
Ibazizumab: The first monoclonal antibody used to treat HIV-1 infection Ibazizumab: The first monoclonal antibody used to treat HIV-1...
NEJM: Dexamethasone does not increase infection risks at surgical site NEJM: Dexamethasone does not increase infection risks at surgical...
TransCon PTH: New hope for patients with Hypoparathyroidism (HP) TransCon PTH: New hope for patients with Hypoparathyroidism (HP). Hypoparathyroidism (HP)...
Breast Cancer Res: New drug lasoxifene may help treat drug-resistant breast cancer Breast Cancer Res: New drug lasoxifene may...
Bristol-Myers' cardiac myosin allosteric inhibitor mavacamten Phase 3 trials Bristol-Myers' cardiac myosin allosteric inhibitor mavacamten Phase 3 trials. Hypertrophic cardiomyopathy...
FDA approved the first C3 inhibitor Empaveli to treat paroxysmal nocturnal hemoglobinuria (PNH)! FDA approved Empaveli to treat paroxysmal...
Roche COVID-19 diagnosis and treatment strategy! Roche COVID-19 diagnosis and treatment strategy! Companies, either big or small, should...
The neuroprotective effect of caffeine in hypoxic-ischemic events The neuroprotective effect of caffeine in hypoxic-ischemic events. Low doses of...
Overview of clinical trials of TROP-2 ADC drugs Overview of clinical trials of TROP-2 ADC drugs. Human trophoblast cell...
What is the role of "enzymes" for various Polymerase chain reaction (PCR)? What is the role of various Polymerase...
Monjuvi: New immune-enhancing antibody for DLBCL enters Phase 3 trials Monjuvi: New immune-enhancing antibody for DLBCL enters Phase 3...